Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patients with Acute Lacunar Infarction Have Benefit from Intravenous Thrombolysis.
Zivanovic Z, Gubi M, Vlahovic D, Milicevic M, Jovicevic M, Lucic A, Ruzicka-Kaloci S, Radovanovic B, Zikic TR, Zarkov M, Popovic N, Slankamenac P. Zivanovic Z, et al. Among authors: milicevic m. J Stroke Cerebrovasc Dis. 2019 Feb;28(2):435-440. doi: 10.1016/j.jstrokecerebrovasdis.2018.10.020. Epub 2018 Nov 6. J Stroke Cerebrovasc Dis. 2019. PMID: 30409747
The Impact of Comorbidity on Rehabilitation Outcome after Ischemic Stroke.
Simić-Panić D, Bošković K, Milićević M, Rabi Žikić T, Cvjetković Bošnjak M, Tomašević-Todorović S, Jovićević M. Simić-Panić D, et al. Among authors: milicevic m. Acta Clin Croat. 2018 Mar;57(1):5-15. doi: 10.20471/acc.2018.57.01.01. Acta Clin Croat. 2018. PMID: 30256006 Free PMC article.
Mixed domain coherent link with electrically reconfigurable IMDD and coherent modes for O-band data center applications.
Misak S, Wissing A, Liu J, Arrunategui-Norvick V, Maharry A, Andrade H, Milicevic M, Chansky E, Movaghar G, Du X, Gilardi G, Kumar R, Su GL, Liu A, Akulova Y, Buckwalter JF, Saleh AAM, Coldren L, Schow CL. Misak S, et al. Among authors: milicevic m. Opt Express. 2024 Oct 21;32(22):38550-38559. doi: 10.1364/OE.532184. Opt Express. 2024. PMID: 39573694 Free article.
Comparison of a Novel Liquid Embolic System with Commonly Used Embolic Agents in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas: A Single-Center Experience.
Nedeljkovic Z, Vukasinovic I, Petrovic M, Nedeljkovic A, Nastasovic T, Bascarevic V, Micovic M, Milicevic M, Milic M, Jovanovic N, Stanimirovic A, Scepanovic V, Grujicic D. Nedeljkovic Z, et al. Among authors: milicevic m. J Clin Med. 2024 Oct 2;13(19):5899. doi: 10.3390/jcm13195899. J Clin Med. 2024. PMID: 39407961 Free PMC article.
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
NIHR Global Health Research Unit on Global Surgery; STARSurg Collaborative. NIHR Global Health Research Unit on Global Surgery, et al. Lancet Digit Health. 2024 Jul;6(7):e507-e519. doi: 10.1016/S2589-7500(24)00065-7. Lancet Digit Health. 2024. PMID: 38906616 Free article.
Pineal Tumor Surgery-The Choice of the Approach Related to Tumor Characteristics and Posterior Fossa Anatomy.
Milisavljević F, Ilić R, Bogdanović I, Milin-Lazović J, Miljković A, Milićević M, Šćepanović V, Stanimirović A, Nastasović T, Lazić I, Jovanović M, Grujičić D. Milisavljević F, et al. Among authors: milicevic m. World Neurosurg. 2024 Aug;188:e531-e539. doi: 10.1016/j.wneu.2024.05.148. Epub 2024 May 29. World Neurosurg. 2024. PMID: 38821399
Secondary vs. primary pituitary xanthogranulomas: which yellow is more mellow?
Miljic D, Pekic S, Doknic M, Stojanovic M, Ilic S, Djurovic MN, Jemuovic Z, Milojevic T, Milicevic M, Jovanovic M, Medic Stojanoska M, Carić B, Radic N, Medenica S, Manojlovic Gacic E, Petakov M. Miljic D, et al. Among authors: milicevic m. Endocr J. 2024 Mar 28;71(3):285-293. doi: 10.1507/endocrj.EJ23-0398. Epub 2024 Jan 27. Endocr J. 2024. PMID: 38281757 Free article.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
228 results